AGN-229666 for the Treatment of Allergic Conjunctivitis

NCT01754766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: AGN-229666
OTHER: vehicle of AGN-229666

Sponsor

Allergan